Search alternatives:
patient decrease » point decrease (Expand Search), transient decrease (Expand Search), largest decrease (Expand Search)
we decrease » _ decrease (Expand Search), mean decrease (Expand Search), teer decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
_ patient » _ patients (Expand Search)
Showing 1 - 20 results of 7,659 for search '(( third ((((we decrease) OR (a decrease))) OR (nn decrease)) ) OR ( _ patient decrease ))', query time: 0.53s Refine Results
  1. 1
    Third.

    Third. by Cuicui Liu (1496260)

    Published 2024
    Save to List
    Saved in:
  2. 2
    Validation of child labor measures using third-party data, households with all children in school.

    Validation of child labor measures using third-party data, households with all children in school. by Guilherme Lichand (11410286)

    Published 2025
    Save to List
    Saved in:
  3. 3
    Table 1_Higher oxidative balance score is associated with a decreased risk of infertility: an analysis of NHANES 2013–2020.docx

    Table 1_Higher oxidative balance score is associated with a decreased risk of infertility: an analysis of NHANES 2013–2020.docx by Mingjun Ma (11518765)

    Published 2025
    Save to List
    Saved in:
  4. 4
    DataSheet1_Decreasing viscosity and increasing accessible load by replacing classical diluents with a hydrotrope in liquid–liquid extraction.docx

    DataSheet1_Decreasing viscosity and increasing accessible load by replacing classical diluents with a hydrotrope in liquid–liquid extraction.docx by Asmae El Maangar (19690522)

    Published 2025
    “…We show that using hydrotropes as a diluent decreases the viscosity of solutions by more than a factor of ten, even under high load by extracted cations. …”
    Save to List
    Saved in:
  5. 5
    Maternal group B <i>Streptococcus</i> decreases infant length and alters the early-life microbiome: a prospective cohort study

    Maternal group B <i>Streptococcus</i> decreases infant length and alters the early-life microbiome: a prospective cohort study by Shanshan Li (114847)

    Published 2024
    “…This study aimed to explore the effects of maternal vaginal GBS during pregnancy on early infant growth, microbiome, and metabolomics.</p> <p>We recruited and classified 453 pregnant women from southern China into GBS or healthy groups based on GBS vaginal colonization. …”
    Save to List
    Saved in:
  6. 6
    These subfigures show a visualization of the context embeddings for the DSVAE model with LS=2=4,CS=2. The first subfigure from the left shows three patient clusters, the second subfigure both patients and controls, the third colors context embeddings based on the subject’s age, and the last subfigure colors the context embeddings based on the subject’s cognitive score, CMINDs.

    These subfigures show a visualization of the context embeddings for the DSVAE model with LS=2=4,CS=2. The first subfigure from the left shows three patient clusters, the second sub... by Eloy Geenjaar (21533195)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 7
    Maximum IFN concentrations are decreased in severe patients.

    Maximum IFN concentrations are decreased in severe patients. by Sonia T. Gazeau (21512764)

    Published 2025
    Save to List
    Saved in:
  8. 8
    Flow diagram of patient selection for the study.

    Flow diagram of patient selection for the study. by Yusuke Fuchioka (22806178)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 9
    Experimental validation revealed that ACADSB and ACADM decreased in patients with UC.

    Experimental validation revealed that ACADSB and ACADM decreased in patients with UC. by Hongliang Chen (538815)

    Published 2025
    Save to List
    Saved in:
  10. 10
    Fuchioka dataset 251021.

    Fuchioka dataset 251021. by Yusuke Fuchioka (22806178)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 11
    Additional file 7 of Decreased complement 4 and interleukin-10 as biomarkers in aqueous humour for non-exudative age-related macular degeneration: a case control study

    Additional file 7 of Decreased complement 4 and interleukin-10 as biomarkers in aqueous humour for non-exudative age-related macular degeneration: a case control study by Juliane Schikora (20871169)

    Published 2025
    Save to List
    Saved in:
  12. 12
    Additional file 3 of Decreased complement 4 and interleukin-10 as biomarkers in aqueous humour for non-exudative age-related macular degeneration: a case control study

    Additional file 3 of Decreased complement 4 and interleukin-10 as biomarkers in aqueous humour for non-exudative age-related macular degeneration: a case control study by Juliane Schikora (20871169)

    Published 2025
    Save to List
    Saved in:
  13. 13
    Table6_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx

    Table6_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx by J. Riera-Arnau (20431328)

    Published 2024
    “…In the sensitivity analysis, the A-level usage rate decreased to one-third and the B-level usage rate increased by 2–3 times. …”
    Save to List
    Saved in:
  14. 14
    Table4_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx

    Table4_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx by J. Riera-Arnau (20431328)

    Published 2024
    “…In the sensitivity analysis, the A-level usage rate decreased to one-third and the B-level usage rate increased by 2–3 times. …”
    Save to List
    Saved in:
  15. 15
    Table2_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx

    Table2_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx by J. Riera-Arnau (20431328)

    Published 2024
    “…In the sensitivity analysis, the A-level usage rate decreased to one-third and the B-level usage rate increased by 2–3 times. …”
    Save to List
    Saved in:
  16. 16
    Table8_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx

    Table8_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx by J. Riera-Arnau (20431328)

    Published 2024
    “…In the sensitivity analysis, the A-level usage rate decreased to one-third and the B-level usage rate increased by 2–3 times. …”
    Save to List
    Saved in:
  17. 17
    Table5_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx

    Table5_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx by J. Riera-Arnau (20431328)

    Published 2024
    “…In the sensitivity analysis, the A-level usage rate decreased to one-third and the B-level usage rate increased by 2–3 times. …”
    Save to List
    Saved in:
  18. 18
    Table3_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx

    Table3_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx by J. Riera-Arnau (20431328)

    Published 2024
    “…In the sensitivity analysis, the A-level usage rate decreased to one-third and the B-level usage rate increased by 2–3 times. …”
    Save to List
    Saved in:
  19. 19
    Table7_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx

    Table7_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx by J. Riera-Arnau (20431328)

    Published 2024
    “…In the sensitivity analysis, the A-level usage rate decreased to one-third and the B-level usage rate increased by 2–3 times. …”
    Save to List
    Saved in:
  20. 20
    Table1_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.DOCX

    Table1_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.DOCX by J. Riera-Arnau (20431328)

    Published 2024
    “…In the sensitivity analysis, the A-level usage rate decreased to one-third and the B-level usage rate increased by 2–3 times. …”
    Save to List
    Saved in:

Search Tools: